Filter
3318
Filtered Results: 3318
Text search:
immunisation
Featured
Recommendations
306
New Publications
1064
Language
Document type
No document type
1969
Guidelines
407
Studies & Reports
399
Strategic & Response Plan
153
Manuals
151
Fact sheets
84
Training Material
55
Situation Updates
46
Resource Platforms
19
Infographics
14
Brochures
8
Videos
8
Online Courses
5
Countries / Regions
India
171
Kenya
122
Global
103
Nepal
91
Nigeria
89
South Africa
88
Uganda
87
Liberia
78
Sierra Leone
77
Ethiopia
68
Bangladesh
62
Myanmar / Burma
60
Congo, Democratic Republic of
58
Ghana
54
Rwanda
54
Zambia
54
Tanzania
52
Malawi
47
Africa
46
Latin America and the Carribbean
45
Philippines
38
Syria
34
Namibia
32
Indonesia
30
Brazil
29
Haiti
27
Lesotho
26
Western and Central Europe
26
Ukraine
24
Zimbabwe
24
Cambodia
24
Pakistan
24
Senegal
22
Guinea
20
Mozambique
20
Burkina Faso
19
South Sudan
19
East and Southern Africa
18
Botswana
18
South–East Asia Region
17
Afghanistan
16
Russia
16
Yemen
16
West and Central Africa
15
Middle East and North Africa
15
Germany
14
Venezuela
13
Cameroon
11
Asia
11
Central African Republic
11
Eswatini/ Swaziland
11
Eastern Europe and Central Asia
10
Lebanon
9
Mali
8
Madagascar
8
Colombia
7
Paraguay
7
Jordan
6
Argentina
6
Eastern Europe
6
Sudan
6
Iraq
6
Niger
5
Bolivia
5
Papua New Guinea
5
Moldova
5
Somalia
5
Chile
4
Albania
4
Burundi
4
Western Pacific Region
4
Ecuador
4
Benin
3
Togo
3
China
3
Laos
3
Côte d’Ivoire / Ivory Coast
3
Egypt
3
Palestine
3
Timor Leste/ East Timor
2
Thailand
2
Mexico
2
Turkey
2
Fiji
2
Peru
2
Bulgaria
2
Turkmenistan
2
United Kingdom
2
Southern Africa
2
Sri Lanka
2
Angola
2
Chad
2
Libya
2
Tajikistan
1
Gambia
1
Iran
1
Canada
1
Singapore
1
Morocco
1
Qatar
1
USA
1
Guinea-Bissau
1
Hungary
1
Saudi Arabia
1
North America
1
Japan
1
Maldives
1
Mauritius
1
Tunisia
1
Vietnam
1
Djibouti
1
Romania
1
Slovakia
1
Greece
1
Georgia
1
Poland
1
Authors & Publishers
Publication Years
Category
Countries
1625
Clinical Guidelines
279
Women & Child Health
262
Public Health
167
Key Resources
113
Capacity Building
63
Pharmacy & Technologies
22
Annual Report MEDBOX
1
Toolboxes
COVID-19
403
Rapid Response
130
HIV
126
TB
105
Ebola
89
Caregiver
86
Conflict
86
AMR
82
Polio
70
Pharmacy
66
Disability
59
Refugee
58
Mental Health
51
Global Health Education
51
NTDs
37
Health Financing Toolbox
37
Planetary Health
35
Natural Hazards
28
Cholera
26
NCDs
19
Zika
19
Specific Hazards
4
South Sudan
1
Typhoon
1
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass...
The objective of Critical Considerations and Actions for Achieving Universal Access to Sexual and Reproductive Health in the Context of Universal Health Coverage through a Primary Health Care Approach is to provide guidance to WHO Member States for ensuring progress towards universal access to compr...
La fiebre amarilla es una enfermedad endémica en varios países de América Latina. Con vistas a brindar apoyo a los responsables de la toma de decisiones para priorizar las acciones preventivas frente a esta afección, la Organización Panamericana de la Salud presenta estos perfiles nacionales co...
EN ESTA EDICIÓN: Vacunación oral contra el cólera en la isla de La Española | Segunda reunión anual de la Comisión Regional de Monitoreo y Reverificación de la Eliminación del Sarampión y la Rubéola | Certificados digitales como ejemplo de transformación digital en la inmunización | La O...
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t...
This report started with a simple question—“How can we tell how much funding is devoted to global health programs?”—and ended (more than two years later) with an answer that is far from simple. As those who have tried know well, tracking health-related funding is challenging in any setting, ...
The COVID-19 pandemic has resulted in a double shock - health and economic. As of March 1, 2021, COVID-19 has cost more than 2.5 million lives and triggered an economic recession surpassing any economic downturn since World War II.
Part I of this paper explores the impact of this current macro-fisc...
The majority of developing countries will fail to achieve their targets for Universal Health Coverage (UHC)1 and the health- and poverty-related Sustainable Development Goals (SDGs) unless they take urgent steps to strengthen their health financing. Just over a decade out from the SDG deadline of 20...
The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i...
The ongoing COVID-19 pandemic has shown that public financial management (PFM) should be an integral part of the response. Effectiveness in financing the health response depends not only on the level of funding but also on the way public funds are allocated and spent, this is determined by the PFM r...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...
With sustained economic growth in many parts of the developing world, an increasing number of countries are transitioning away from the most subsidized development finance as they exceed income and other qualification requirements. Cross-country evidence suggests that Development Assistance Committe...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
Cholera remains a significant public health threat in many countries worldwide. In resource-constrained settings, it disproportionately affects thousands of poor and vulnerable population
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est...
